首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy
【24h】

A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy

机译:避免自我聚集并改善光动力疗法中使用的酞菁衍生物的体外和体内皮肤递送的递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

The hydrophilic character and aggregation phenomena exhibited by the photosensitizer zinc phthalocyanine tetrasulfonate (ZnPcSO_4) make it difficult for this compound to penetrate the skin, and reduce the compound's photodynamic efficacy. A microemulsion (ME) was developed to increase the skin penetration of ZnPcSO_4 while avoiding its aggregation. Ternary phase diagrams composed of surfactants (Span? 80/Tween? 80), canola oil and a propylene glycol (PG)/water mixture (3:1) were constructed as a basis for choosing an adequate ME preparation. Rheological, electrical conductivity, dynamic light scattering and zeta potential studies were carried out to characterize the ME formulations. Monomerization of ZnPcSO_4 in the ME was determined photometrically and fluorometrically. In vitro skin penetration and retention of the compound in the skin were measured using porcine ear skin mounted on a diffusion cell apparatus. The in vivo accumulation 6 h after ZnPcSO_4 application was determined fluorometrically in hairless mice skin. Confocal laser scanning microscopy was used to visualize ZnPcSO _4 distribution in the skin. A ME composed of canola oil:surfactant:PG-water at 38:47:15 (w/w/w) was chosen for ZnPcSO_4. This was oil-in-water with internal phase diameter of 15.7 ± 0.15 nm. Spectroscopic techniques confirmed that the ME was able to keep ZnPcSO _4 in its monomeric form. In the in vitro penetration of ZnPcSO _4 in the stratum corneum (SC) and in epidermis (without stratum corneum) with dermis ([E + D]) was 33.0- and 28.0-fold higher, respectively compared to the control solution of the drug. In vivo studies, confirmed that when the ME was used as carrier, ZnPcSO_4 concentrations in the SC and [E + D] were about 1.6- and 5.6-fold higher, respectively, than controls. Visualization of ZnPcSO_4 skin penetration by confocal laser scanning microscopy confirmed that the ME increased both penetration and biodistribution of this photosensitizer in the skin.
机译:光敏剂酞菁锌四磺酸锌(ZnPcSO_4)表现出的亲水特性和聚集现象使该化合物难以渗透皮肤,并降低了该化合物的光动力功效。开发了微乳液(ME),以增加ZnPcSO_4的皮肤渗透性,同时避免其聚集。构建了由表面活性剂(Span?80 / Tween?80),低芥酸菜子油和丙二醇(PG)/水混合物(3:1)组成的三元相图,作为选择合适的ME制剂的基础。进行流变学,电导率,动态光散射和ζ电势研究以表征ME制剂。用光度法和荧光法测定了ZnPcSO_4在ME中的单体化。使用安装在扩散池装置上的猪耳皮肤来测量化合物在体外的皮肤渗透和在皮肤中的保留。荧光测定无毛小鼠皮肤中ZnPcSO_4施用后6 h的体内积累。使用共聚焦激光扫描显微镜观察皮肤中ZnPcSO_4的分布。对于ZnPcSO_4,选择了38:47:15(w / w / w)的低芥酸菜籽油:表面活性剂:PG-水组成的ME。这是内部相直径为15.7±0.15 nm的水包油。光谱技术证实了ME能够将ZnPcSO _4保持为单体形式。与药物的对照溶液相比,ZnPcSO _4在角质层(SC)和表皮(无角质层)中的真皮渗透率([E + D])分别高33.0和28.0倍。体内研究证实,当使用ME作为载体时,SC和[E + D]中的ZnPcSO_4浓度分别比对照高约1.6倍和5.6倍。通过共聚焦激光扫描显微镜对ZnPcSO_4皮肤渗透的可视化证实,ME增强了该光敏剂在皮肤中的渗透和生物分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号